The Gordon and Betty Moore Foundation is pleased to announce a new funding opportunity as a part of its Diagnostic Excellence Initiative. The initiative aims to reduce harm from erroneous or delayed diagnoses, reduce costs and redundancy in the diagnostic process, improve health outcomes and save lives.
The foundation is soliciting novel ideas and approaches for developing new clinical measures to improve diagnosis, specifically targeting three major categories of disease: acute vascular events (such as stroke and myocardial infarction), infections (such as sepsis and pneumonia) and cancer (such as lung and colorectal cancer).
The application process will involve a multi-phased competitive process. Ultimately, 3-6 grants will be awarded for $250,000 to $500,000 each for work done over 12-18 months.
The Diagnostic Excellence Initiative addresses a pressing need to improve diagnostic performance. Over the last few decades, significant progress has been made in medication safety and therapeutics, but work has been slow to address diagnosis. Twelve million Americans experience a diagnostic error each year, and it is likely that each of us will experience a diagnostic error in our lifetime. Delayed or missed diagnoses result in delays in treatment, allow undiagnosed conditions to persist or even progress and worsen outcomes. The development of clinical measures in diagnosis will provide clinicians and medical institutions the ability to track and measure their success and failure rates, giving them an opportunity to solve deficiencies and implement innovations to improve.
Previous work by the Moore Foundation includes the launch of the Betty Irene Moore School of Nursing, as well as a number of special projects. The current request for ideas addresses an important challenge for health care, and adds to the commitment made by the foundation to improve the experiences and outcomes of patient care.